Join the watch

Altimmune, Inc.

Dividend yield
Payout ratio
P/E (12m)
Altimmune, Inc. description

Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company, which is focused on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. Its portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Company profile
Market cap
Nano (43.71M)
Company CEO
Vipin K. Garg
ALT dividends payouts